388 related articles for article (PubMed ID: 15096193)
1. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin.
Esin S; Batoni G; Pardini M; Favilli F; Bottai D; Maisetta G; Florio W; Vanacore R; Wigzell H; Campa M
Immunology; 2004 May; 112(1):143-52. PubMed ID: 15096193
[TBL] [Abstract][Full Text] [Related]
2. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
3. Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG).
Marras F; Bozzano F; Bentivoglio G; Ugolotti E; Biassoni R; Moretta L; De Maria A
Eur J Immunol; 2012 Sep; 42(9):2459-70. PubMed ID: 22736333
[TBL] [Abstract][Full Text] [Related]
4. Bovine natural killer cells restrict the replication of Mycobacterium bovis in bovine macrophages and enhance IL-12 release by infected macrophages.
Denis M; Keen DL; Parlane NA; Storset AK; Buddle BM
Tuberculosis (Edinb); 2007 Jan; 87(1):53-62. PubMed ID: 16730232
[TBL] [Abstract][Full Text] [Related]
5. Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages.
Endsley JJ; Endsley MA; Estes DM
J Leukoc Biol; 2006 Jan; 79(1):71-9. PubMed ID: 16275895
[TBL] [Abstract][Full Text] [Related]
6. [Bacillus Calmette-Guérin enhances the function of human nature killer cells by inducing IL-12 production and IL-12R expression].
Zhou H; Fan YY; Wu CY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):976-9. PubMed ID: 19900360
[TBL] [Abstract][Full Text] [Related]
7. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC.
Marcenaro E; Ferranti B; Falco M; Moretta L; Moretta A
Int Immunol; 2008 Sep; 20(9):1155-67. PubMed ID: 18596023
[TBL] [Abstract][Full Text] [Related]
8. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
Hoft DF; Brown RM; Roodman ST
J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
[TBL] [Abstract][Full Text] [Related]
9. Bovine NK cells acquire cytotoxic activity and produce IFN-gamma after stimulation by Mycobacterium bovis BCG- or Babesia bovis-exposed splenic dendritic cells.
Bastos RG; Johnson WC; Mwangi W; Brown WC; Goff WL
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):302-12. PubMed ID: 18514329
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-12 regulates the production of Bacille Calmette-Guérin-induced interferon-gamma from human cells in a CD40-dependent manner.
Méndez-Samperio P; Ayala-Verdin HE; Trejo-Echeverria A
Scand J Immunol; 1999 Jul; 50(1):61-7. PubMed ID: 10404053
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.
Kaleab B; Ottenoff T; Converse P; Halapi E; Tadesse G; Rottenberg M; Kiessling R
Eur J Immunol; 1990 Dec; 20(12):2651-9. PubMed ID: 2269329
[TBL] [Abstract][Full Text] [Related]
12. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
Iho S; Yamamoto T; Takahashi T; Yamamoto S
J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
[TBL] [Abstract][Full Text] [Related]
13. Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes.
Feinberg J; Fieschi C; Doffinger R; Feinberg M; Leclerc T; Boisson-Dupuis S; Picard C; Bustamante J; Chapgier A; Filipe-Santos O; Ku CL; de Beaucoudrey L; Reichenbach J; Antoni G; Baldé R; Alcaïs A; Casanova JL
Eur J Immunol; 2004 Nov; 34(11):3276-84. PubMed ID: 15384045
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
[TBL] [Abstract][Full Text] [Related]
15. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
16. Adaptive immunity in the colostrum-deprived calf: response to early vaccination with Mycobacterium bovis strain bacille Calmette Guerin and ovalbumin.
Nonnecke BJ; Waters WR; Goff JP; Foote MR
J Dairy Sci; 2012 Jan; 95(1):221-39. PubMed ID: 22192201
[TBL] [Abstract][Full Text] [Related]
17. Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein.
Ab BK; Kiessling R; Van Embden JD; Thole JE; Kumararatne DS; Pisa P; Wondimu A; Ottenhoff TH
Eur J Immunol; 1990 Feb; 20(2):369-77. PubMed ID: 1690136
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
19. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
20. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation.
Schierloh P; Alemán M; Yokobori N; Alves L; Roldán N; Abbate E; del C Sasiain M; de la Barrera S
Immunology; 2005 Dec; 116(4):541-52. PubMed ID: 16313368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
